Nanoassemblies based on non-ionic amphiphilic cyclodextrin hosting Zn(II)-phthalocyanine and docetaxel: Design, physicochemical properties and intracellular effects

Jiang, 2011, Adv. Colloid Interface Sci., 169, 13, 10.1016/j.cis.2011.07.002 Voskuhl, 2009, Chem. Soc. Rev., 38, 495, 10.1039/B803782P Duchene, 1999, J. Control. Release, 62, 263, 10.1016/S0168-3659(99)00046-2 Le, 2014, Colloids Surf. B:Biointerfaces, 123, 486, 10.1016/j.colsurfb.2014.09.010 Bonnet, 2015, Drug Discov. Today, 20, 1120, 10.1016/j.drudis.2015.05.008 Mavridis, 2015, Int. J. Pharm., 492, 275, 10.1016/j.ijpharm.2015.06.004 Bilensoy, 2009, Expert Opin. Drug Deliv., 6, 1161, 10.1517/17425240903222218 Roux, 2007, J. Eur. Biophys., 36, 861, 10.1007/s00249-007-0207-6 Perret, 2011, In Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications, 197 Quaglia, 2009, Biomaterials, 30, 374, 10.1016/j.biomaterials.2008.09.035 Memisoglu-Bilensoy, 2005, J. Control. Release, 104, 489, 10.1016/j.jconrel.2005.03.006 Bilensoy, 2008, Int. J. Pharm., 347, 163, 10.1016/j.ijpharm.2007.06.051 Cirpanli, 2009, Eur. J. Pharm. Biopharm., 73, 82, 10.1016/j.ejpb.2009.04.013 Scala, 2011, MedChemComm, 2, 172, 10.1039/C0MD00190B Al-Abd, 2010, J. Control. Release, 142, 101, 10.1016/j.jconrel.2009.10.003 Agostinis, 2011, CA Cancer J. Clin., 61, 250, 10.3322/caac.20114 Kemp, 2016, Adv. Drug Deliv. Rev., 98, 3, 10.1016/j.addr.2015.10.019 Dewaele, 2010, Methods Mol. Biol., 635, 7, 10.1007/978-1-60761-697-9_2 Juarranz, 2008, Clin. Transl. Oncol., 10, 148, 10.1007/s12094-008-0172-2 Chatterjee, 2008, Adv. Drug. Delivery Rev., 60, 1627, 10.1016/j.addr.2008.08.003 C. Conte, F. Ungaro, A. Mazzaglia, F. Quaglia, In: Alonso M. J. and Garcia⿿Fuentes M. eds. Nano-Oncologicals: New Targeting and Delivery Approaches. Advances in Delivery Science and Technology, p. 123⿿160, New York : CRS Springer. Conte, 2013, J. Control Release, 167, 40, 10.1016/j.jconrel.2012.12.026 Skupin-Mrugalska, 2013, Drug Discov. Today, 18, 776, 10.1016/j.drudis.2013.04.003 Lau, 2011, Chem. Commun., 47, 9657, 10.1039/c1cc13783b Voskuhl, 2013, J. Soft Matter, 9, 2453, 10.1039/c2sm27353e Silva, 2011, Nanotechnology, 11, 4046 Kralova, 2010, J. Med. Chem., 53, 128, 10.1021/jm9007278 Kolarova, 2005, Toxicol. In Vitro, 19, 971, 10.1016/j.tiv.2005.06.015 Iohara, 2012, J. Pharm. Sci., 101, 3390, 10.1002/jps.23045 Hegge, 2012, J. Pharm. Sci., 101, 1524, 10.1002/jps.23046 Mazzaglia, 2011, Chem Commun., 47, 9140, 10.1039/c1cc12821c O'Mahony, 2012, Eur. J. Pharm. Sci., 47, 896, 10.1016/j.ejps.2012.08.020 Kandoth, 2012, Chem. Eur. J, 18, 1684, 10.1002/chem.201101635 Conte, 2014, RSC Adv., 4, 43903, 10.1039/C4RA07847K Mazzaglia, 2011, In Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine Current and Future Industrial Applications, 343 McMahon, 2012, J. Pharm. Pharmacol., 64, 1063, 10.1111/j.2042-7158.2012.01497.x Zhang, 2015, ACS Nano, 9, 9741, 10.1021/acsnano.5b02513 Gangopadhyay, 2015, Photochem. Photobiol. Sci, 14, 1329, 10.1039/C5PP00057B Mazzaglia, 2001, Eur. J. Org. Chem, 9, 1715, 10.1002/1099-0690(200105)2001:9<1715::AID-EJOC1715>3.0.CO;2-A Mastino, 1997, Cell Death Differ., 4, 629, 10.1038/sj.cdd.4400289 Stancanelli, 2010, J. Pharm. Sci., 99, 3141, 10.1002/jps.22065 Ivanova, 2011, J. Phys. Chem. B, 115, 902, 10.1021/jp109738e Mazzaferro, 2011, Int. J. Pharm., 416, 171, 10.1016/j.ijpharm.2011.06.034 Kettel, 2014, ACS Appl. Mater. Interfaces, 6, 2300, 10.1021/am404126r Raffaini, 2016, Beilstein J. Org. Chem., 12, 73, 10.3762/bjoc.12.8 Lackowicz, 1999 Mazzaglia, 2006, Molecular recognition by means of photophysical investigation, in Cyclodextrins Materials: Photochemistry, Photophysics and Photobiology, 203 Tang, 2005, Photochem. Photobiol., 81, 242, 10.1562/2004-05-24-RA-176.1 Sun, 2015, Int. J. Pharm., 478, 308, 10.1016/j.ijpharm.2014.11.052 Morse, 2005, Mol. Cancer Ther., 4, 1495, 10.1158/1535-7163.MCT-05-0130